Intelicare Holdings Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de Intelicare Holdings han disminuido a una tasa media anual de -7.8%, mientras que en la industria Healthcare Services los beneficios crecieron en un 14.3% anualmente. Los ingresos han ido disminuyendo a una tasa media de 4.2% al año.

Información clave

-7.8%

Tasa de crecimiento de los beneficios

18.1%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare Services	42.6%
Tasa de crecimiento de los ingresos	-4.2%
Rentabilidad financiera	-154.0%
Margen neto	-375.2%
Última actualización de beneficios	31 Dec 2023

Actualizaciones de resultados anteriores recientes

Recent updates

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Intelicare Holdings. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

CHIA:ICR Ingresos, gastos y beneficios (AUD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A	Gastos de I+D
31 Dec 23	0	-1	2	0
30 Sep 23	0	-2	2	0
30 Jun 23	0	-3	2	0
31 Mar 23	0	-4	2	0
31 Dec 22	0	-4	2	0
30 Sep 22	0	-4	2	0
30 Jun 22	0	-4	2	0
31 Mar 22	0	-4	3	0
31 Dec 21	0	-5	3	0
30 Sep 21	0	-5	3	0
30 Jun 21	0	-4	3	0
31 Mar 21	0	-3	2	0
31 Dec 20	1	-2	1	0
30 Sep 20	0	-2	1	0
30 Jun 20	0	-3	1	0
30 Jun 19	0	0	0	1
30 Jun 18	0	0	0	0

Ingresos de calidad: ICR actualmente no es rentable.

Margen de beneficios creciente: ICR actualmente no es rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: ICR no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 7.8% al año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de ICR en el último año con su promedio de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: ICR no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Healthcare Services (14.3%).

Rentabilidad financiera

Alta ROE: ICR tiene una rentabilidad financiera negativa (-153.99%), ya que actualmente no es rentable.

Intelicare Holdings Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Información clave

Actualizaciones de resultados anteriores recientes

Full year 2023 earnings released: AU$0.018 loss per share (vs AU$0.038 loss in FY 2022)

First half 2023 earnings released: AU$0.018 loss per share (vs AU$0.02 loss in 1H 2022)

Full year 2022 earnings released: AU$0.038 loss per share (vs AU$0.058 loss in FY 2021)

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

Full year 2021 earnings released: AU$0.058 loss per share (vs AU$0.06 loss in FY 2020)

First half 2021 earnings released: AU$0.016 loss per share (vs AU$0.026 loss in 1H 2020)

Recent updates

Intelicare Holdings Limited, Annual General Meeting, May 31, 2024

Less than half of directors are independent

New major risk - Financial position

Less than half of directors are independent

Less than half of directors are independent

Intelicare Holdings Limited has filed a Follow-on Equity Offering in the amount of AUD 0.6 million.

Intelicare Holdings Limited has filed a Follow-on Equity Offering in the amount of AUD 0.6 million.

Intelicare Holdings Limited has filed a Follow-on Equity Offering in the amount of AUD 0.6 million.

Less than half of directors are independent

Intelicare Holdings Limited, Annual General Meeting, Nov 28, 2023

Less than half of directors are independent

Full year 2023 earnings released: AU$0.018 loss per share (vs AU$0.038 loss in FY 2022)

New minor risk - Financial data availability

Less than half of directors are independent

Less than half of directors are independent

InteliCare Holdings Ltd Announces Step Down of Scott Taylor as Non-Executive Director, Effective 13 June 2023

Less than half of directors are independent

Less than half of directors are independent

First half 2023 earnings released: AU$0.018 loss per share (vs AU$0.02 loss in 1H 2022)

Intelicare Holdings Limited Announces an Expansion of Their Services to Include Personal Emergency Response

Intelicare Holdings Limited, Annual General Meeting, Nov 29, 2022

Intelicare Holdings Limited Announces Director Changes

Full year 2022 earnings released: AU$0.038 loss per share (vs AU$0.058 loss in FY 2021)

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Intelicare Holdings Limited Announces Major Board Appointments and New Strategic Direction

Intelicare Holdings Limited Announces Executive Changes

Less than half of directors are independent

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

InteliCare Holdings Ltd Announces Board and Committee Changes

Full year 2021 earnings released: AU$0.058 loss per share (vs AU$0.06 loss in FY 2020)

Intelicare Holdings Limited announced that it expects to receive AUD 2.573 million in funding

InteliCare Holdings Ltd Announces Appointment of Gary Elwell of Gap Corporate Services as Chief Financial Officer

New 90-day high: AU$0.30

First half 2021 earnings released: AU$0.016 loss per share (vs AU$0.026 loss in 1H 2020)

InteliCare Holdings Ltd Signs Five Year Strategic Supply Agreement with Optus Networks Pty Ltd

New 90-day low: AU$0.23

Full year earnings released - AU$0.06 loss per share

Intelicare Holdings Limited Launches B2C Strategy with New Online Sales Platform and Ecommerce Marketplace

New 90-day low: AU$0.27

New 90-day low - AU$0.30

Desglose de ingresos y gastosBeta

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Desglose de ingresos y gastos
Beta